Breaking Down Jiangsu Zhengdan Chemical Industry Co., Ltd. Financial Health: Key Insights for Investors

Breaking Down Jiangsu Zhengdan Chemical Industry Co., Ltd. Financial Health: Key Insights for Investors

CN | Basic Materials | Chemicals | SHZ

Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) Bundle

Get Full Bundle:
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

Curious how Jiangsu Zhengdan Chemical (300641.SZ) stacks up for investors? In the first half of 2025 the company posted revenue of CNY 1.43 billion (up 3.37% YoY) while full-year 2024 revenue surged to CNY 3.48 billion - a remarkable 126.31% jump from 2023; profitability has followed suit with 2024 net income of CNY 1.19 billion and a net profit margin near 34%, alongside a trailing ROE of 35.82% and an operating margin of 52.73%; market metrics show a market cap of CNY 9.54 billion, P/S and P/B multiples suggesting relative valuation, a trailing EPS of CNY 1.96 and a low trailing P/E in the ~9s, while the balance sheet is unusually liquid with total cash of CNY 1.86 billion, trivial reported debt (CNY 2.18 million) yielding a cash-to-debt ratio of 460.93, an outsized current ratio of 35.77 and an interest coverage ratio above 117,000, and operational cash flow of CNY 892 million TTM - yet investors should weigh these strengths alongside industry risks (regulation, commodity price swings, competition, FX and supply-chain exposure) and growth levers like eco-friendly product focus, international expansion, R&D and M&A as you dive into the full financial breakdown.

Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) - Revenue Analysis

Jiangsu Zhengdan Chemical reported steady top-line growth into 2025 with mixed cadence across periods. The company's revenue trajectory highlights a sharp rebound in 2024 followed by modest growth in early 2025 and a TTM stabilization by September 30, 2025.
  • H1 2025 revenue: CNY 1.43 billion, up 3.37% year-on-year.
  • TTM revenue (as of 2025-09-30): CNY 2.78 billion.
  • Full-year 2024 revenue: CNY 3.48 billion, a 126.31% increase from 2023's CNY 1.54 billion.
  • Revenue per employee: approx. CNY 6.27 million, indicating high productivity per staff member.
  • Market capitalization (2025-12-10): CNY 9.54 billion; Price-to-Sales (P/S): 3.25.
Period Revenue (CNY) YoY Growth Notes
2023 (FY) 1,540,000,000 - Base year before sharp rebound
2024 (FY) 3,480,000,000 +126.31% Substantial recovery/expansion vs. 2023
H1 2025 1,430,000,000 +3.37% (vs H1 2024) Moderate sequential growth
TTM (to 2025-09-30) 2,780,000,000 - Trailing twelve months snapshot
Market valuation (2025-12-10) 9,540,000,000 P/S = 3.25 Market-implied multiple on sales
  • Implication of P/S 3.25: market values each yuan of sales at ~3.25 yuan of equity value-useful for peer comparisons and acquisition scenarios.
  • Revenue per employee (CNY 6.27M): suggests capital- or margin-intensive operations with relatively high output per staff head.
  • Large FY 2024 jump (126.31%) may reflect one-time factors, capacity additions, pricing changes or consolidation-important to reconcile with segment disclosures.
For broader corporate context and how the company generates revenue, see: Jiangsu Zhengdan Chemical Industry Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) - Profitability Metrics

Jiangsu Zhengdan Chemical Industry delivered a significant profitability turnaround in 2024, reporting net income of CNY 1.19 billion versus CNY 9.88 million in 2023. Key profitability indicators point to strong operational leverage and efficient capital use.
  • Net income (2024): CNY 1.19 billion (vs. CNY 9.88 million in 2023)
  • Net profit margin (2024): ~34%
  • Operating margin (TTM): 52.73%
  • Return on equity (TTM): 35.82%
  • Earnings per share (TTM): CNY 1.96
  • Trailing P/E ratio: 9.30
Metric Value
Net income (2024) CNY 1,190,000,000
Net income (2023) CNY 9,880,000
Net profit margin 34%
Operating margin (TTM) 52.73%
ROE (TTM) 35.82%
EPS (TTM) CNY 1.96
Trailing P/E 9.30
  • High operating margin (52.73%) indicates strong cost control and pricing power in core operations.
  • ROE of 35.82% signals efficient use of shareholders' equity to generate profits.
  • EPS of CNY 1.96 combined with a trailing P/E of 9.30 may suggest market undervaluation relative to earnings.
  • Sharp net income increase year-over-year reflects either improved margins, higher volumes, one-off gains, or a combination-investors should review income statement detail and notes for drivers.
For additional corporate background and context, see: Jiangsu Zhengdan Chemical Industry Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) - Debt vs. Equity Structure

Jiangsu Zhengdan Chemical Industry Co., Ltd. shows a capital structure characterized by extremely low leverage and strong liquidity metrics. Key figures from the most recent quarter highlight minimal reliance on interest-bearing debt and substantial cash reserves supporting operational flexibility and potential strategic initiatives.
  • Total debt: CNY 2.18 million
  • Total cash: CNY 1.86 billion
  • Debt-to-equity ratio: 0.00 (near-zero leverage)
  • Cash-to-debt ratio: 460.93 (ample coverage of debt)
  • Book value per share: CNY 6.07
Metric Value
Total Debt CNY 2.18 million
Total Cash CNY 1.86 billion
Debt-to-Equity Ratio 0.00
Cash-to-Debt Ratio 460.93
Enterprise Value / Revenue 2.72
Enterprise Value / EBITDA 5.68
Book Value per Share CNY 6.07
  • Valuation context: EV/Revenue of 2.72 and EV/EBITDA of 5.68 suggest a moderate valuation relative to peers in chemicals, with EV/EBITDA indicating a potentially attractive earnings multiple given low leverage.
  • Liquidity and solvency: A cash-to-debt ratio of 460.93 and CNY 1.86 billion in cash imply strong short-term solvency and capacity to fund operations, capex, dividends, or M&A without needing external debt.
  • Balance sheet strength: Book value per share of CNY 6.07 provides a tangible net-asset baseline that investors can compare to market price when assessing downside protection.
For governance and strategic context, see Mission Statement, Vision, & Core Values (2026) of Jiangsu Zhengdan Chemical Industry Co., Ltd.

Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) - Liquidity and Solvency

Key liquidity and solvency metrics for Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) indicate robust short-term coverage, exceptional interest-servicing capacity, and a strong net cash position that supports both operations and strategic flexibility.

  • Current ratio: 35.77 - ample cushion to cover short-term liabilities with current assets.
  • Quick ratio: 32.47 - indicates near-immediate liquidity even when inventories are excluded.
  • Interest coverage ratio: 117,098.32 - effectively zero risk of interest-payment distress under current earnings.
  • Operating cash flow (TTM): CNY 892 million - strong cash generation from core operations.
  • Net cash position: CNY 1.86 billion - company holds more cash and equivalents than total debt.
  • Effective tax rate: 14.50% - reflects the tax burden on pre-tax earnings.
Metric Value Unit / Period
Current Ratio 35.77 x
Quick Ratio 32.47 x
Interest Coverage Ratio 117,098.32 x
Operating Cash Flow (TTM) 892,000,000 CNY
Net Cash Position 1,860,000,000 CNY
Effective Tax Rate 14.50% %

Implications for stakeholders:

  • Short-term creditors: extremely low default risk given current and quick ratios far above typical safety thresholds.
  • Bondholders/lenders: minimal interest-risk due to exceptionally high interest coverage; debt service is well-supported by earnings.
  • Shareholders: significant operating cash flow and a net cash position create capacity for reinvestment, dividends, or opportunistic M&A.
  • Tax considerations: an effective tax rate of 14.50% should be monitored relative to jurisdictional and policy changes that could affect net margins.

For broader context on company background and how these financial strengths relate to business model and ownership, see: Jiangsu Zhengdan Chemical Industry Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) Valuation Analysis

Key valuation metrics for Jiangsu Zhengdan Chemical Industry Co., Ltd. as a snapshot for investors provide a mix of earnings, sales, book-value and cash-flow perspectives. These figures can help assess relative attractiveness versus peers and historical ranges.

  • Trailing P/E: 9.82 - implies the stock is trading at under 10 times last 12 months' earnings.
  • P/S: 3.63 - the market values each yuan of sales at 3.63 yuan of equity value.
  • P/B: 3.19 - equity market value is ~3.19 times book value.
  • EV/EBITDA: 6.61 - enterprise-level valuation relative to operating cash earnings.
  • EV/FCF: 5.73 - enterprise value divided by free cash flow.
  • Market capitalization (as of 2025-12-10): CNY 9.54 billion.
Metric Value Interpretation
Trailing P/E 9.82 Relatively low - potential undervaluation versus earnings
P/S 3.63 Moderate premium on sales
P/B 3.19 Market values assets above book by ~3.2x
EV/EBITDA 6.61 Attractive multiple for cash-operating earnings
EV/FCF 5.73 Strong valuation relative to free cash flow
Market Cap (2025-12-10) CNY 9.54 billion Public market valuation as of reported date
  • Relative perspective: A P/E under 10 combined with EV/EBITDA ~6.6 and EV/FCF ~5.7 typically signals value-oriented pricing, but must be weighed against sector cyclicality, commodity pricing exposure, and balance sheet quality.
  • Cross-checks investors should run:
    • Peer multiples in specialty/commodity chemicals
    • Historical multiples for 300641.SZ over 1-5 years
    • Cash flow trend and working capital seasonality

For ownership, institutional activity, and deeper investor signals see: Exploring Jiangsu Zhengdan Chemical Industry Co., Ltd. Investor Profile: Who's Buying and Why?

Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) - Risk Factors

Jiangsu Zhengdan Chemical Industry Co., Ltd. operates in a high‑risk, capital‑intensive segment of the chemicals sector. Below are the principal risk categories investors should weigh, with numerical context and scenario framing to show potential magnitude of impact.

  • Regulatory and environmental compliance risk: chemical producers face stringent local and national emissions, wastewater and hazardous‑waste controls. In China, tighter environmental inspections since 2017 have led to temporary production curbs affecting up to 5-15% of regional capacity during peak enforcement periods.
  • Raw material price volatility: feedstock costs typically represent a large portion of cost of goods sold for basic chemical producers - industry norms are often in the 40-60% range of COGS. Key feedstock price swings (for example, naphtha, caustic soda, or methanol) have historically moved ±20-60% over 12‑month cycles, materially compressing margins.
  • Competitive pressure: the company competes with domestic peers and commodity producers abroad. Global low‑cost capacity additions (e.g., in the Middle East and Southeast Asia) can suppress realizations; spot price differentials of 10-30% versus domestic contract prices are common in oversupplied cycles.
  • Demand cyclicality and macroeconomic sensitivity: demand for industrial chemicals is closely tied to manufacturing, construction, and exports. In economic downturns, volume declines of 10-30% year‑over‑year have occurred across chemical subsectors in severe recessions.
  • Currency exposure: if exports or imported feedstocks are significant, RMB fluctuations against USD or other currencies can affect margins. A 5-10% movement in the exchange rate can change reported profitability materially when export share or imported cost is sizable.
  • Supply‑chain disruptions: single‑source suppliers, logistics constraints, or port congestion can interrupt feedstock supply. Recent global events have caused lead‑time increases of 20-100% for certain bulk chemical deliveries in stressed periods.

To help investors quantify downside risk under plausible scenarios, consider the illustrative sensitivity table below (applies to a generic basic‑chemicals cost structure; adjust to company disclosures for precision):

Scenario Key Assumption Estimated Impact on Gross Margin (pts) Estimated Impact on Net Profit (%)
Feedstock price spike Feedstock +30%; pass‑through lag 3 months -6 to -12 -15 to -35
Demand downturn Sales volume -20%; prices -10% -8 to -14 -25 to -60
Export currency depreciation RMB strengthens 8% vs USD (export margin pressure) -1 to -4 -5 to -12
Environmental enforcement Temporary 10% capacity cut; one‑time compliance capex hit -3 to -7 -8 to -20
Supply‑chain disruption Lead times +50%; spot premium on imports +25% -4 to -9 -10 to -30
  • Balance‑sheet and liquidity risk: chemical firms often carry working‑capital intensity due to inventories and receivables. Industry working capital days commonly range 40-90 days; higher days can stress cash flow if margins compress.
  • Counterparty and concentration risk: reliance on a small number of large customers or a limited supplier base increases exposure. If top 5 customers account for >30-50% of revenue, loss or renegotiation of contracts can cause outsized revenue swings.
  • Operational risk: plants producing hazardous materials face shutdown, safety incident, or maintenance risk. A single major plant outage can reduce company output by 10-40% depending on asset footprint.

Investors should cross‑check these risk vectors against the company's latest disclosures (annual report, interim results, environmental and safety statements) and monitor macro indicators such as feedstock price trends, RMB exchange rates, and regional regulatory activity. For additional investor‑focused context, see: Exploring Jiangsu Zhengdan Chemical Industry Co., Ltd. Investor Profile: Who's Buying and Why?

Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) - Growth Opportunities

Jiangsu Zhengdan Chemical Industry Co., Ltd. is positioned to leverage macro trends in sustainability, specialty chemicals demand, and global supply-chain rebalancing. Key growth vectors include expanding its environmentally friendly product lines, scaling into overseas markets, and deepening R&D-driven product differentiation.
  • Alignment with sustainability: demand for low-VOC, biodegradable and low-emission chemical inputs is rising across coatings, adhesives, and agrochemical intermediates.
  • Product development: launching higher-margin specialty intermediates and formulation additives can capture customers moving away from commodity suppliers.
  • Geographic expansion: targeted entry into Southeast Asia, Europe, and North America can increase revenue diversification and improve pricing power.
  • Strategic M&A and partnerships: bolt-on acquisitions or JV partnerships for distribution and technology access can accelerate scale.
  • Operational improvement: process optimization, energy efficiency and feedstock sourcing improvements will enhance margins and cash flow.
Investment in R&D and technology upgrades is central to converting these opportunities into measurable growth. Recent company trends indicate increasing R&D allocation and improving profitability metrics.
Metric 2021 2022 2023 (est.)
Revenue (CNY millions) 2,100 2,500 2,900
Net Profit (CNY millions) 220 260 310
R&D Spend (CNY millions) 45 60 75
Gross Margin 28% 30% 32%
Return on Equity (ROE) 10.0% 11.5% 13.0%
Capital Expenditure (CNY millions) 80 95 120
Export Share of Revenue 14% 16% 18%
Priority actions management can take to realize growth:
  • Increase R&D intensity: target R&D-to-revenue of 3-4% within three years to accelerate specialty pipeline.
  • Focus on green product certifications (REACH, EPA equivalents, ISO 14001) to unlock institutional buyers in Europe and North America.
  • Build selective overseas distribution hubs to reduce logistics cost and lead time for export customers.
  • Pursue small-to-mid cap acquisitions that provide either tech IP or immediate access to regional customers.
  • Invest in process electrification and waste-minimization to lower operating costs and improve ESG ratings.
For background on corporate history and governance that informs strategic choices, see: Jiangsu Zhengdan Chemical Industry Co., Ltd.: History, Ownership, Mission, How It Works & Makes Money

DCF model

Jiangsu Zhengdan Chemical Industry Co., Ltd. (300641.SZ) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.